Mass spectrometry-based diagnostics: The upcoming revolution in disease detection

被引：71

作者：

Petricoin, EF ^{[1
]}

Liotta, LA

机构：

[1] NCI, US FDA, Clin Proteom Program, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA

[2] NCI, US FDA, Clin Proteom Program, Lab Pathol,Ctr Canc Res, Bethesda, MD 20892 USA

来源：

CLINICAL CHEMISTRY | 2003年 / 49卷 / 04期

关键词：

D O I：

10.1373/49.4.533

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：533 / 534

页数：2

共 21 条

[1]

Adam BL, 2001, PROTEOMICS, V1, P1264, DOI 10.1002/1615-9861(200110)1:10<1264::AID-PROT1264>3.0.CO

[2]

2-R

[3]

Adam BL, 2002, CANCER RES, V62, P3609

[4] Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: A novel approach to identify DNA-mismatch repair-deficient cancer cells [J].

Bonk, T ;

Humeny, A ;

Gebert, J ;

Sutter, C ;

Doeberitz, MV ;

Becker, CM .

CLINICAL CHEMISTRY, 2003, 49 (04) :552-561

[5] MALDI-TOF-MS analysis of protein and DNA [J].

Bonk, T ;

Humeny, A .

NEUROSCIENTIST, 2001, 7 (01) :6-12

[6] Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer [J].

Carter, D ;

Douglass, JF ;

Cornellison, CD ;

Retter, MW ;

Johnson, JC ;

Bennington, AA ;

Fleming, TP ;

Reed, SG ;

Houghton, RL ;

Diamond, DL ;

Vedvick, TS .

BIOCHEMISTRY, 2002, 41 (21) :6714-6722

[7]

Christensen CM, 2000, HARVARD BUS REV, V78, P102

[8]

Clarke Stephen, 2002, Br J Biomed Sci, V59, P42

[9]

Coile Jr RC, 2000, RUSS COILLES HLTH TR, V12, P2

[10] Proteomic patterns in serum and identification of ovarian cancer [J].

Diamandis, EP .

LANCET, 2002, 360 (9327) :170-170

← 1 2 3 →